Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Free Cash Flow (2020 - 2025)

BioAtla (BCAB) has 6 years of Free Cash Flow data on record, last reported at -$9.9 million in Q3 2025.

  • For Q3 2025, Free Cash Flow fell 92.54% year-over-year to -$9.9 million; the TTM value through Sep 2025 reached -$57.1 million, up 32.92%, while the annual FY2024 figure was -$71.9 million, 30.91% up from the prior year.
  • Free Cash Flow reached -$9.9 million in Q3 2025 per BCAB's latest filing, up from -$14.1 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$5.1 million in Q3 2024 and bottomed at -$30.8 million in Q1 2024.
  • Average Free Cash Flow over 5 years is -$19.5 million, with a median of -$19.2 million recorded in 2024.
  • Peak YoY movement for Free Cash Flow: tumbled 361.95% in 2021, then skyrocketed 81.25% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at -$21.9 million in 2021, then fell by 11.35% to -$24.3 million in 2022, then dropped by 22.93% to -$29.9 million in 2023, then surged by 43.93% to -$16.8 million in 2024, then skyrocketed by 41.12% to -$9.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Free Cash Flow were -$9.9 million in Q3 2025, -$14.1 million in Q2 2025, and -$16.3 million in Q1 2025.